Quick Answer
Advanced Biomed Inc. reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
Advanced Biomed Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.16 | -14.3% |
| 2024 | -$0.14 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.31 | +720.0% | +1650.0% |
| September 30, 2025 | -$0.02 | -100.0% | +71.4% |
| March 31, 2025 | -$0.07 | -40.0% | -40.0% |
| December 31, 2024 | -$0.05 | -400.0% | -400.0% |
| September 30, 2024 | -$0.01 | — | +80.0% |
| March 31, 2024 | -$0.05 | — | -400.0% |
| December 31, 2023 | -$0.01 | — | — |
- Advanced Biomed Inc. showed a decrease of -14.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2024–2025 period, Advanced Biomed Inc.’s diluted eps has declined by 14.3% (from $0.14 per share (loss) to $0.16 per share (loss)).
- The most recent figure is from Advanced Biomed Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: